Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)
Clinical trial NCT04978818 · COMPLETED
Trial details
- NCT number
- NCT04978818
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2023-10-26
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.